Related Experiment Video
Updated: Jul 10, 2025
15:42
Xenotransplantation of Human Stem Cells into the Chicken Embryo
Published on: July 11, 2010
19.3K
Engineering Equity Into the Promise of Xenotransplantation
Peter P Reese1, Neil R Powe2, Bernard Lo3
1Renal-Electrolyte and Hypertension Division, Department of Medicine and Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Summary
Xenotransplantation, using genetically engineered pig organs, offers a solution to kidney transplant shortages. A framework is proposed to ensure equitable access for all patients, especially minority groups, in clinical trials and future care.
Area of Science:
- Organ transplantation
- Xenotransplantation
- Biotechnology
Background:
- Kidney transplantation faces organ shortages and access inequities.
- Xenotransplantation, using genetically modified pig organs, presents a potential solution.
- Advances in gene editing enable the creation of modified porcine organs for human transplantation.
Purpose of the Study:
- To provide a framework for promoting equity in xenotransplantation.
- To guide industry, regulators, payers, and healthcare professionals.
- To ensure equitable access for patients with end-stage kidney disease.
Main Methods:
- Developing a framework for equitable implementation of xenotransplantation.
- Recommending industry partnerships with diverse patient populations.
- Advocating for community engagement and addressing concerns.
Main Results:
- A proposed framework to ensure equitable access to xenotransplantation.
- Emphasis on patient advocacy boards and community outreach.
- Strategies for integrating diverse patient groups into clinical trials.
Conclusions:
- Xenotransplantation holds promise for addressing organ shortages.
- Equitable access must be a priority from clinical trials to routine care.
- Proactive community engagement is crucial for successful xenotransplantation implementation.
